PC1 0.00% 0.0¢ plus connect limited

looking interesting - trials soon

  1. 70 Posts.
    good opportunity to get in today while the stock is still cheap. Full Phase II trials of their cancer vaccine is due to start in a couple of weeks. Their vaccine is not cancer specific, being applicable to 50% of cancers.

    There are speculation that the trials will be successive.

    "We speculate that these patients might respond more strongly to the therapy as their prior treatment with hormone suppressing drugsis likely to have boosted their T- cell levels as per the impact demonstrated by Norwood Abbey's thymus research."

GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.